MM13843 - National Coverage Determination 210.15: Pre-Exposure Prophylaxis (PrEP) for HIV Prevention
This new Article comprises Subregulatory Guidance for:
• National coverage of Pre-exposure prophylaxis (PrEP) using FDA-approved antiretroviral drugs to prevent HIV
• HCPCS and diagnosis codes
• Billing and payment requirements
MLN Matters (MM) Articles are based on information contained within Change Requests (CRs). In this case, this article is based on content within CR13843 that is posted on the CMS website at https://www.cms.gov/files/document/r12987cp.pdf and https://www.cms.gov/files/document/r12987ncd.pdf.
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: December 06, 2024
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.